Labsamera - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 30,203 | 28,909 | 133,474 | 316,186 | 511,923 | 872,433 | 1,292,352 | 1,486,641 |
| Profit before tax | -8,264 | 3,268 | -50,949 | 33,230 | 35,520 | 50,822 | 168,445 | 236,995 |
| Net profit | -8,264 | 3,219 | -50,949 | 31,711 | 34,484 | 43,199 | 158,775 | 211,418 |
| Equity | -16,920 | -13,652 | -64,652 | -32,941 | 1,543 | 44,742 | 213,197 | 424,616 |
| Liabilities | - | - | - | - | 132,689 | 161,787 | 136,453 | 294,049 |
| Non-current assets | 6,025 | 2,883 | 0 | 15,094 | 80,328 | 75,649 | 90,987 | 227,249 |
| Current assets | 9,664 | 16,004 | 56,430 | 122,315 | 142,227 | 243,483 | 382,135 | 649,949 |
| Total assets | 15,689 | 18,887 | 56,430 | 137,409 | 222,555 | 319,132 | 473,122 | 877,198 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 49,209 | 72,236 | 135,246 |
| Social insurance contributions | - | - | - | - | - | 14,010 | 45,305 | 67,497 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | -4.3% | +361.7% | +136.9% | +61.9% | +70.4% | +48.1% | +15.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -52.7% | 17.0% | -90.3% | 23.1% | 15.5% | 13.5% | 33.6% | 24.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 2234.9% | 96.6% | 74.5% | 49.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -27.4% | 11.1% | -38.2% | 10.0% | 6.7% | 5.0% | 12.3% | 14.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -27.4% | 11.3% | -38.2% | 10.5% | 6.9% | 5.8% | 13.0% | 15.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 86.0 | 3.6 | 0.6 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 133,474 | 237,145 | 191,969 | 232,649 | 161,544 | 145,038 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Labsamera - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-27 | 2026-03-27 | 4048.99 |
| 2026-03-17 | 2026-03-22 | 4048.99 |
| 2024-01-16 | 2024-01-18 | 748.12 |
| 2023-07-19 | 2023-07-20 | 1480.85 |
Labsamera - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-29 | 2026-02-16 | 0.41 |
| 2026-01-27 | 2026-01-28 | 0.03 |
| 2026-01-17 | 2026-01-20 | 0.38 |
| 2026-01-16 | 2026-01-16 | 872.15 |
| 2026-01-15 | 2026-01-15 | 951.27 |
| 2026-01-01 | 2026-01-14 | 0.38 |
| 2025-12-18 | 2025-12-18 | 0.38 |
| 2025-05-17 | 2025-05-19 | 1411.25 |
| 2024-11-06 | 2024-11-18 | 5.63 |
| 2024-10-04 | 2024-11-05 | 0.31 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Labsamera, MB (code 304522059) is a small partnership engaged in the manufacture of other organic basic chemicals. In the latest financial year, 2025, the company generated revenue of EUR 1.49 million, up 15.0% year on year and 70.4% over two years. Net profit rose to EUR 211.4 thousand, compared with EUR 158.8 thousand in 2024 and EUR 43.2 thousand in 2023, showing a clear upward profitability trend. The net profit margin improved from 5.0% in 2023 to 12.3% in 2024 and 14.2% in 2025. Balance sheet totals also expanded materially: assets increased to EUR 877.2 thousand, equity to EUR 424.6 thousand, and liabilities to EUR 294.0 thousand. The equity ratio stood at 48.4%, while debt-to-equity was 0.69. Efficiency remained solid, with asset turnover at 1.69x. Revenue per employee was EUR 148.7 thousand and profit per employee EUR 21.1 thousand, indicating strong productivity in 2025.